Integra LifeSciences Holdings Shares Outstanding 2010-2024 | IART

Integra LifeSciences Holdings shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Integra LifeSciences Holdings Annual Shares Outstanding
(Millions of Shares)
2023 80
2022 84
2021 85
2020 85
2019 86
2018 84
2017 79
2016 79
2015 71
2014 66
2013 58
2012 57
2011 59
2010 60
2009 59
Integra LifeSciences Holdings Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 76
2024-06-30 77
2024-03-31 78
2023-12-31 80
2023-09-30 80
2023-06-30 81
2023-03-31 82
2022-12-31 84
2022-09-30 83
2022-06-30 84
2022-03-31 84
2021-12-31 85
2021-09-30 85
2021-06-30 85
2021-03-31 85
2020-12-31 85
2020-09-30 85
2020-06-30 85
2020-03-31 86
2019-12-31 86
2019-09-30 86
2019-06-30 86
2019-03-31 86
2018-12-31 84
2018-09-30 86
2018-06-30 84
2018-03-31 80
2017-12-31 79
2017-09-30 79
2017-06-30 79
2017-03-31 78
2016-12-31 79
2016-09-30 81
2016-06-30 79
2016-03-31 76
2015-12-31 71
2015-09-30 71
2015-06-30 68
2015-03-31 67
2014-12-31 66
2014-09-30 66
2014-06-30 66
2014-03-31 66
2013-12-31 58
2013-09-30 56
2013-06-30 56
2013-03-31 56
2012-12-31 57
2012-09-30 58
2012-06-30 57
2012-03-31 57
2011-12-31 59
2011-09-30 58
2011-06-30 60
2011-03-31 60
2010-12-31 60
2010-09-30 60
2010-06-30 61
2010-03-31 60
2009-12-31 59
2009-09-30 59
2009-06-30 58
2009-03-31 59
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.864B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.393B 24.93
Intuitive Surgical (ISRG) United States $193.619B 101.23
Edwards Lifesciences (EW) United States $43.533B 27.64
Alcon (ALC) Switzerland $42.700B 28.57
IQVIA Holdings (IQV) United States $36.494B 20.11
IDEXX Laboratories (IDXX) United States $35.790B 42.15
DexCom (DXCM) United States $31.431B 47.33
Waters (WAT) United States $22.876B 33.83
STERIS (STE) Ireland $20.691B 23.82
SONOVA HOLDING (SONVY) Switzerland $19.760B 0.00
Hologic (HOLX) United States $17.141B 18.51
Fresenius Medical Care AG KGaA (FMS) Germany $14.008B 14.38
Sysmex ADR (SSMXY) Japan $12.776B 40.07
Globus Medical (GMED) United States $11.294B 28.60
Penumbra (PEN) United States $9.735B 95.36
Masimo (MASI) United States $9.336B 45.18
Teleflex (TFX) United States $8.528B 13.60
Glaukos (GKOS) United States $7.879B 0.00
PROCEPT BioRobotics (PRCT) United States $4.728B 0.00
Integer Holdings (ITGR) United States $4.717B 26.73
Inari Medical (NARI) United States $3.408B 0.00
Veracyte (VCYT) United States $3.372B 101.19
LivaNova (LIVN) United Kingdom $2.796B 16.14
Nihon Kohden (NHNKY) Japan $2.337B 17.75
Tandem Diabetes Care (TNDM) United States $2.267B 0.00
TransMedics (TMDX) United States $2.261B 71.66
Elekta AB (EKTAY) Sweden $2.229B 20.04
RxSight (RXST) United States $1.515B 0.00
Alphatec Holdings (ATEC) United States $1.374B 0.00
Artivion (AORT) United States $1.254B 83.11
OPKO Health (OPK) United States $1.085B 0.00
Pulse Biosciences (PLSE) United States $1.062B 0.00
Paragon 28 (FNA) United States $0.874B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.859B 14.60
ORTHOFIX MEDICAL INC (OFIX) United States $0.708B 0.00
Mesa Laboratories (MLAB) United States $0.699B 16.49
IRadimed (IRMD) United States $0.699B 37.80
AxoGen (AXGN) United States $0.654B 0.00
Pacific Biosciences Of California (PACB) United States $0.622B 0.00
SiBone (SIBN) United States $0.580B 0.00
OrthoPediatrics (KIDS) United States $0.558B 0.00
Semler Scientific (SMLR) United States $0.535B 31.48
Treace Medical Concepts (TMCI) United States $0.488B 0.00
ClearPoint Neuro (CLPT) United States $0.453B 0.00
Tactile Systems Technology (TCMD) United States $0.440B 23.83
Delcath Systems (DCTH) United States $0.392B 0.00
AngioDynamics (ANGO) United States $0.370B 0.00
NeuroPace (NPCE) United States $0.331B 0.00
CVRx (CVRX) United States $0.330B 0.00
Inogen (INGN) United States $0.230B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
Accuray (ARAY) United States $0.204B 0.00
Sight Sciences (SGHT) United States $0.198B 0.00
KORU Medical Systems (KRMD) United States $0.177B 0.00
Nevro (NVRO) United States $0.162B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.141B 15.12
Spectral Diagnostics (EDTXF) Canada $0.104B 0.00
Vicarious Surgical (RBOT) United States $0.094B 0.00
Monogram Orthopaedics (MGRM) United States $0.089B 0.00
LENSAR (LNSR) United States $0.089B 0.00
WORK Medical Technology Group (WOK) China $0.087B 0.00
InspireMD (NSPR) Israel $0.083B 0.00
EDAP TMS S.A (EDAP) France $0.082B 0.00
908 Devices (MASS) United States $0.079B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.051B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Spectral AI (MDAI) United States $0.039B 0.00
Neuronetics (STIM) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Accelerate Diagnostics (AXDX) United States $0.033B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.027B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
T2 Biosystems (TTOO) United States $0.010B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00